ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript
ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc.
Resmed Inc (RMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 2,800 | $535,976 | -75% | 0.17% | |
| 2. | 900 | $172,278 | -94% | 0.05% | |
| 3. | Neo Ivy Capital Renee Yao | 15,476 | $2,962 | 0.58% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.13 | 2,487 | Director | 19,216 | 2016-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $192.97 | 14,683 | Officer | 440,799 | 2024-07-08 | Filing | |
| $194.35 | 1,000 | Officer | 90,056 | 2024-07-08 | Filing | |
| $209.81 | 1,000 | Officer | 91,056 | 2024-06-10 | Filing | |
| $211.66 | 14,683 | Officer | 440,799 | 2024-06-07 | Filing | |
| $218.29 | 360 | Director | 7,519 | 2024-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,743,457 | $3,052,229,474 | 0.06% | |
| 2. | 12,248,180 | $2,106,931,925 | 0.05% | |
| 3. | 6,290,089 | $1,082,021,110 | 0.05% | |
| 4. | 3,435,280 | $589,462,559 | 0.06% | |
| 5. | 2,529,218 | $435,076,071 | 0.03% |
News See All
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
ResMed Inc. (NYSE:RMD) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the ResMed Second Quarter Fiscal Year 2024 Earnings Conference Call and Webcast.
ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript
Operator: Hello, and welcome to the ResMed First Quarter Fiscal Year 2024 Earnings Conference Call and Webcast [Operator Instructions]. As a reminder, this conference is being recorded.
5 Oversold Healthcare Stocks to Buy
Root, Switzerland-based NovoCure Limited (NASDAQ:NVCR) is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization...
5 Oversold Growth Stocks To Buy
In this piece, we will take a look at the five oversold growth stocks to buy.
ResMed Inc. (NYSE:RMD) Q4 2023 Earnings Call Transcript
Operator: Hello, and welcome to ResMed's Fourth Quarter Fiscal Year 2023 Earnings Conference Call and Webcast. [Operator Instructions].
Billionaire Ken Griffin's 2023 Portfolio: Top 15 Stock Picks
The stock market crash of 2022 hammered several major hedge funds. One of the biggest funds that bled capital last year is Chase Coleman and Feroze Dewan's Tiger Global.
Hedge Fund and Insider Trading News: Ray Dalio, George Soros, Bill Ackman, Steven Cohen, Elliott Management, Electronic Arts Inc. (EA), DISH Network Corp (DISH), and More
Bridgewater Associates, one of the world's largest hedge funds, sold U.S. bank stocks in the first quarter as the collapse of regional lenders rattled investors, according to regulatory filings.